Канада - Енглески - Health Canada

generic medical partners inc - daunorubicin (daunorubicin hydrochloride) - solution - 20mg - daunorubicin (daunorubicin hydrochloride) 20mg - antineoplastic agents

Канада - Енглески - Health Canada

generic medical partners inc - daunorubicin (daunorubicin hydrochloride) - solution - 50mg - daunorubicin (daunorubicin hydrochloride) 50mg - antineoplastic agents

Канада - Енглески - Health Canada

hikma canada limited - daunorubicin (daunorubicin hydrochloride) - solution - 20mg - daunorubicin (daunorubicin hydrochloride) 20mg

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - lignocaine hydrochloride anhydrous -

Перу - Шпански - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

gp pharm s.a. - clorhidrato de daunorubicina; - polvo liofilizado para solucion inyectable - por vial - daunorubicina

Перу - Шпански - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

medifarma s.a. - droguerÍa - clorhidrato de daunorubicina; - polvo para solucion inyectable - por vial - - daunorubicina

Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

zentiva pharma uk ltd - daunorubicin hydrochloride - powder for solution for infusion - 20mg

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - daunorubicin hydrochloride, quantity: 2.14 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - - acute lymphocytic (lymphoblastic) leukaemia. daunorubicin is usually reserved for use in cases shown to be resistant to other drugs. however, combined treatment with daunorubicin, vincristine and a steroid has been used in the early stages of the disease. - acute myeloblastic leukaemia. daunorubicin has been used in all stages, alone or in combination with other cytotoxic agents e.g., cytarabine. - disseminated solid tumours. daunorubicin has been investigated for use in these tumours and found to be effective in some cases of disseminated neuroblastoma and rhabdomyosarcoma.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

fresenius kabi usa, llc - mitoxantrone hydrochloride (unii: u6usw86rd0) (mitoxantrone - unii:bz114nvm5p) - mitoxantrone 2 mg in 1 ml - mitoxantrone injection, usp is indicated for reducing neurologic disability and/or the frequency of clinical relapses in patients with secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis (i.e., patients whose neurologic status is significantly abnormal between relapses). mitoxantrone injection, usp is not indicated in the treatment of patients with primary progressive multiple sclerosis. the clinical patterns of multiple sclerosis in the studies were characterized as follows: secondary progressive and progressive relapsing disease were characterized by gradual increasing disability with or without superimposed clinical relapses, and worsening relapsing-remitting disease was characterized by clinical relapses resulting in a step-wise worsening of disability.  mitoxantrone injection, usp in combination with corticosteroids is indicated as initial chemotherapy for the treatment of patients with pain related to advanced hormone-refractory prostate cancer. mi

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - mitozantrone hydrochloride, quantity: 23.284 mg (equivalent: mitozantrone, qty 20 mg) - injection, solution - excipient ingredients: water for injections; sodium acetate; sodium sulfate; nitrogen; dilute hydrochloric acid; glacial acetic acid; sodium chloride - the treatment of metastatic carcinoma of the breast, non-hodgkin's lymphoma, adult acute non-lymphocytic leukaemia (anll) and chronic myelogenous leukaemia in blast crisis.